nygazet.com logo
Novo Nordisk (NVO) earnings Q2 2025
business

Novo Nordisk (NVO) earnings Q2 2025

1 min read

Novo Nordisk last week cut its full-year guidance and named Mike Doustdar as its new CEO.

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Sales of Novo Nordisk 's blockbuster Wegovy weight loss drug surged in the second quarter, the company said in its latest report, as it pledged to reduce costs... [1161 chars]

Read Original Article

Source: CNBC

Visit Source

Share this article